STAT

Everything (or almost everything) you need to know about importing drugs from Canada

The logic behind the idea is simple enough. But will Trump’s latest proposal actually save you money at the pharmacy counter? We’ve got answers.
Source: J. Scott Applewhite/AP

WASHINGTON — President Trump’s new plan to import cheaper drugs from Canada seems like a no-brainer. But like most things in health care, it’s complicated.

The logic is simple enough: Canadians buy the same drugs, made by the same manufacturers, but they get them at a much cheaper cost. So, says Trump, let’s take their drugs.

It’s also wildly popular: 80% of Americans said in a recent survey they support importing prescription drugs, making the idea one of the most well-liked drug pricing proposals currently being considered in Washington.

But the questions abound: Can Trump do this under existing law? Can Canada keep up with American demand? And can Trump get such an ambitious plan across the finish line before the 2020 election?

And then there’s the biggest concern of all: Is the Trump administration opening Americans up to dangerous,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks